Computational Based Identified EAAT2 Transporter Activator Attenuates Amyloid‐β Induced Excitotoxicity in Primary Neuronal‐Astroglial Mixed Culture by Ameliorating Glutamate Clearance

Jan 3, 2026Chemical biology & drug design

Computer-Found EAAT2 Activator May Reduce Amyloid-β Toxicity by Improving Glutamate Cleanup in Brain Cell Cultures

AI simplified

Alzheimers & Treatments on OpenScience ↗PubMed ↗DOI ↗

Abstract

PTID and NDHP significantly enhanced EAAT2 expression and function, reducing extracellular glutamate levels in Aβ-intoxicated cultures.

Astrocytes are vital for maintaining synaptic health and regulating neurotransmitter levels, which are essential for cognition.
In Alzheimer's disease, dysfunction of astrocytes accelerates disease progression and contributes to cognitive decline.
Aβ deposition leads to oxidative changes in the glutamate transporter EAAT2, impairing glutamate uptake and increasing harmful glutamate levels.
Restoring EAAT2 function is important for mitigating excitotoxicity and preserving neuronal health.
Three potential allosteric modulators of EAAT2 were identified and tested for their ability to enhance EAAT2 activity.
PTID and NDHP showed neuroprotective effects by promoting dendritic growth and increasing the number of healthy neurons and astrocytes.

AI simplified

Astrocytes play a central role in maintaining synaptic homeostasis, regulating neurotransmitter clearance, and supporting neuronal function, all of which are integral to cognition. In Alzheimer's brain, astrocytic dysfunction contributes significantly to the rapid progression of the disease pathology. Aβ deposition induces oxidative alterations in the astrocytic glutamate transporter EAAT2, leading to impaired glutamate uptake and elevated extracellular glutamate levels, which drive excitotoxicity. This disruption adversely impacts synaptic plasticity, neuronal survival, and cognitive integrity, highlighting the pivotal role of astrocytes in the early phases of AD. Restoration of EAAT2 function is critical to mitigating disease progression and preserving cognitive function. Through in silico analyses, three potential allosteric modulators of EAAT2 were identified. These compounds were further tested on Aβ-intoxicated primary neuronal-astrocyte mixed cultures, with their efficacy evaluated via immunoblotting for EAAT2 expression, in vitro glutamate assays for functional assessment, and morphological analyses of astrocytes and neurons using GFAP and β-III tubulin markers. Notably, PTID and NDHP significantly enhanced EAAT2 expression and function, reducing extracellular glutamate levels and ameliorating excitotoxic damage. Moreover, these compounds demonstrated neuroprotective effects by promoting dendritic growth and branching in β-III tubulin-positive neurons. Immunocytochemical analyses further revealed an increased number of β-III tubulin and GFAP-positive cells, suggesting that PTID and NDHP not only improved neuronal integrity but also supported astrocytic resilience and functionality. The findings of the current study underscore the critical role of astrocytes in glutamate homeostasis and cognition, showcasing the therapeutic potential of EAAT2 allosteric modulators, particularly PTID and NDHP, in alleviating Aβ-induced neurotoxicity. By enhancing EAAT2 function, these modulators restore astrocytic support for synaptic health, offering a promising avenue for addressing cognitive decline in AD.

Full Text

Full text is available at the source.

View full text ↗

Computational Based Identified EAAT2 Transporter Activator Attenuates Amyloid‐β Induced Excitotoxicity in Primary Neuronal‐Astroglial Mixed Culture by Ameliorating Glutamate Clearance

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the alzheimers & treatments brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the alzheimers & treatments brief